AARD Stock Analysis: Buy, Sell, or Hold?
AARD - Aardvark Therapeutics, Inc. Common Stock
$7.60
2.60 (52.00%)
▲
5d:
+33.33%
30d:
+112.29%
90d:
+94.87%
WAIT
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 12, 2026
29d
Get Alerted When AARD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: AARD is 37.4% above its trading range ($5.53). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: AARD is 37.4% above its trading range ($5.53). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: AARD is currently trading at $7.60, which is considered extended relative to its 30-day fair value range of $3.58 to $5.53.
Technical Outlook: Technically, AARD is in a downtrend. Immediate support is located at $4.63, while resistance sits at $7.92. The stock is showing strong short-term momentum, up 52.0% recently.
Market Sentiment: AARD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.44 (+103.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AARD is in a downtrend. Immediate support is located at $4.63, while resistance sits at $7.92. The stock is showing strong short-term momentum, up 52.0% recently.
Market Sentiment: AARD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.44 (+103.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.58 -
$5.53
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+37.4% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+52.0%)
- BULLISH: Trading 103.2% below Wall St target ($15.44)
- WARNING: Recommendation downgraded due to 37.4% overvaluation
Trading Range Analysis
30-Day Trading Range
$3.58 -
$5.53
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.63
Resistance Level
$7.92
Current Trend
Downtrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.35
Wall Street Target
$15.44
(+103.2%)
Share & Embed Analysis
Last updated: July 13, 2026 1:27 AM ET
Data refreshes hourly during market hours. Next update: 2:27 AM
Data refreshes hourly during market hours. Next update: 2:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AARD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$36 | 63 BUY |
